Cabinet approves ₹24,474 cr fertiliser subsidy to support farmers
Cabinet also nods to a biotechnology scheme, Bio-RIDE, with a budget of ₹9,197 crore to harness bio-innovation potential
Cabinet also nods to a biotechnology scheme, Bio-RIDE, with a budget of ₹9,197 crore to harness bio-innovation potential
Post listing, Concord Biotech shares gained 26.2% to hit a high of ₹934.90 on the BSE, while it touched a high of ₹925.90 on the NSE, up 25% against the IPO price.
At the heart of the crisis-led watershed moment is an unprecedented scale of digital adoption across government agencies, industries, medical bodies, and enterprises.
Bharat Biotech, founded by Krishna Ella and his wife Suchitra, has been at the forefront of making vaccines for a while. Yet it took a global pandemic for the spotlight to shine on the company.
The Pune-based company is pioneering the production of test kits to screen for Covid-19. With fresh funding, it hopes to rapidly ramp up capacity.